These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31136931)

  • 1. Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam.
    Nguyen TS; Nguyen TLH; Pham TTV; Hua S; Ngo QC; Li SC
    Respir Med; 2019 Jul; 153():31-37. PubMed ID: 31136931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of a pharmacist-driven intervention in COPD (EPIC): study protocol for a randomized controlled trial.
    Davis E; Marra C; Gamble JM; Farrell J; Lockyer J; FitzGerald JM; Abu-Ashour W; Gillis C; Hawboldt J
    Trials; 2016 Oct; 17(1):502. PubMed ID: 27737686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of targeting disease and medication management interventions towards patients with COPD.
    van Boven JF; Stuurman-Bieze AG; Hiddink EG; Postma MJ
    Curr Med Res Opin; 2016; 32(2):229-39. PubMed ID: 26479017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with medication adherence in patients with chronic obstructive pulmonary disease.
    Ágh T; Inotai A; Mészáros Á
    Respiration; 2011; 82(4):328-34. PubMed ID: 21454953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study.
    Kokturk N; Polatli M; Oguzulgen IK; Saleemi S; Al Ghobain M; Khan J; Doble A; Tariq L; Aziz F; El Hasnaoui A
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1377-1388. PubMed ID: 29731625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of community pharmacists in COPD management: Inhalation technique and medication adherence.
    Hesso I; Gebara SN; Kayyali R
    Respir Med; 2016 Sep; 118():22-30. PubMed ID: 27578467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of pharmaceutical care on health outcomes in patients with COPD.
    Jarab AS; Alqudah SG; Khdour M; Shamssain M; Mukattash TL
    Int J Clin Pharm; 2012 Feb; 34(1):53-62. PubMed ID: 22101426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring variables associated with medication non-adherence in patients with COPD.
    Jarab AS; Mukattash TL
    Int J Clin Pharm; 2019 Oct; 41(5):1202-1209. PubMed ID: 31468254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structured pharmacist-led intervention programme to improve medication adherence in COPD patients: A randomized controlled study.
    Abdulsalim S; Unnikrishnan MK; Manu MK; Alrasheedy AA; Godman B; Morisky DE
    Res Social Adm Pharm; 2018 Oct; 14(10):909-914. PubMed ID: 29104008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of clinical pharmacist intervention on medication adherence in patients with chronic obstructive pulmonary disease - A randomized controlled study.
    Nguyen T; Truong MTX; Lam DN; Nguyen HTT; Huynh AM; Duong VK; Vo TPM; Nguyen TH; Cao TTM; Pham ST; Tran BLT; Van Nguyen L
    Patient Educ Couns; 2024 Jan; 118():108037. PubMed ID: 37931404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a network system for providing proper inhalation technique by community pharmacists on clinical outcomes in COPD patients.
    Takemura M; Mitsui K; Ido M; Matsumoto M; Koyama M; Inoue D; Takamatsu K; Itotani R; Ishitoko M; Suzuki S; Aihara K; Sakuramoto M; Kagioka H; Fukui M
    Int J Chron Obstruct Pulmon Dis; 2013; 8():239-44. PubMed ID: 23696699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigating the association between medication adherence and health-related quality of life in COPD: Methodological challenges when using a proxy measure of adherence.
    Boland MR; van Boven JF; Kruis AL; Chavannes NH; van der Molen T; Goossens LM; Rutten-van Mölken MP
    Respir Med; 2016 Jan; 110():34-45. PubMed ID: 26639189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medication adherence and health-related quality of life among patients with chronic obstructive pulmonary disease.
    Horvat N; Locatelli I; Kos M; Janežič A
    Acta Pharm; 2018 Mar; 68(1):117-125. PubMed ID: 29453914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence.
    Krauskopf K; Federman AD; Kale MS; Sigel KM; Martynenko M; O'Conor R; Wolf MS; Leventhal H; Wisnivesky JP
    COPD; 2015 Apr; 12(2):151-64. PubMed ID: 24960306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.
    Koehorst-Ter Huurne K; Kort S; van der Palen J; van Beurden WJ; Movig KL; van der Valk P; Brusse-Keizer M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1679-88. PubMed ID: 27555758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of a medication adherence management intervention in a community pharmacy setting: a cluster randomised controlled trial.
    Torres-Robles A; Benrimoj SI; Gastelurrutia MA; Martinez-Martinez F; Peiro T; Perez-Escamilla B; Rogers K; Valverde-Merino I; Varas-Doval R; Garcia-Cardenas V
    BMJ Qual Saf; 2022 Feb; 31(2):105-115. PubMed ID: 33782092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of symptom burden and adherence to respiratory medications in individuals self-reporting a diagnosis of COPD within a community pharmacy setting.
    Bollmeier SG; Seaton TL; Prosser TR; Chou YT; Reckenberg K; Hahn B; Stanford RH; Ray R
    J Am Pharm Assoc (2003); 2019; 59(4):479-488.e1. PubMed ID: 31126830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of clinical pharmacist intervention on health-related quality of life in chronic obstructive pulmonary disorder patients - a randomized controlled study.
    Suhaj A; Manu MK; Unnikrishnan MK; Vijayanarayana K; Mallikarjuna Rao C
    J Clin Pharm Ther; 2016 Feb; 41(1):78-83. PubMed ID: 26775599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
    Rutten-van Mölken MP; Oostenbrink JB; Tashkin DP; Burkhart D; Monz BU
    Chest; 2006 Oct; 130(4):1117-28. PubMed ID: 17035446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential risk factors for medication non-adherence in patients with chronic obstructive pulmonary disease (COPD).
    Khdour MR; Hawwa AF; Kidney JC; Smyth BM; McElnay JC
    Eur J Clin Pharmacol; 2012 Oct; 68(10):1365-73. PubMed ID: 22476392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.